Anna Vilgelm, M.D., Ph.D., is assistant professor in the Department of Pathology at the Ohio State University. Her research focuses on the design and preclinical evaluation of novel therapeutic strategies for treatment of metastatic cancers, including breast cancer and melanoma.
